Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles

NCT02862782 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1000

Enrollment

OTHER_GOV

Sponsor class

Conditions

In-vitro Fertilization

Interventions

DRUG: hCG (Ovitrelle 250 mcg mcg - Merck Serono)
DRUG: hCG (Ovitrelle 250 mcg mcg - Merck Serono) + GnRH agonist (Decapeptyl 0.2mg - Ferring Gmgh)

Sponsor

Tel-Aviv Sourasky Medical Center